Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study
Oncology Letters · 23.08.2024 · 28 (5)
DOI: 10.3892/ol.2024.14642 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 23.08.2024. Verfasst von Huina Lv und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China.
- Department of Oncology, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
- Department of Oncology, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China.
Zitieren
APA
Lv, H., Hong, Y., Zhang, Y., Li, S., Li, B., & Zhang, M. (2024). Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study. Oncology Letters, 28(5). https://doi.org/10.3892/ol.2024.14642
Vancouver
Lv H, Hong Y, Zhang Y, Li S, Li B, Zhang M. Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study. Oncology Letters. 2024;28(5). doi:10.3892/ol.2024.14642
BibTeX
@article{Lv2024,
author = {Lv, Huina and Hong, Yanyan and Zhang, Yuting and Li, Siyu and Li, Bingbing and Zhang, Mingjun},
title = {Efficacy and safety of nanoparticle albumin‑bound paclitaxel compared with solvent‑based paclitaxel in adjuvant therapy for breast cancer: A retrospective study},
journal = {Oncology Letters},
year = {2024},
volume = {28},
number = {5},
doi = {10.3892/ol.2024.14642}
}
EUVIMED